BuzzSparks.org

Biosensia


in-vitro diagnostics company

Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro...

Founded in 2006
Homepage:
Total money raised: $4.6M

HQ

Belfield Innovation Park

Dublin
IRL

Phone: +353 1 7163650

Updated on Jun 7, 2013
Biosensia at CrunchBase
Diarmuid Flavin CEO
Past
Diarmuid Flavin Chief Operating Officer

December, 2011

Biosensia raised $1.6M in unattributed round from ACT Venture Capital, Atlantic Bridge, and Seroba Kernel

Biosensia Raises €1.2M in Funding    finsmes.com

February, 2008

Biosensia raised $2.9M in unattributed round from Street Capital, Enterprise Ireland, Seroba Kernel, and Atlantic Bridge

2006

Biosensia was founded in 2006